Sewoon Medical Co. Ltd

100700 · KQ · Healthcare / Healthcare Equipment & Supplies

2,190.00KRW+10.00 (+0.46%)

Price History

Full chart

Market Stats

Previous Close2,180.00

Open2,205.00

Day Range2,180.00 – 2,240.00

52-Week Range2,050.00 – 3,430.00

Volume59.95K

Market Cap96.80B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield2.46%

Beta0.98

50-Day Avg2,360.50

200-Day Avg2,448.03

About

Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical Co., Ltd. was founded in 1982 and is headquartered in Cheonan, South Korea.

Company Details

SectorHealthcare
IndustryHealthcare Equipment & Supplies
CEOMs. Jae-Hee Lee
Employees192
Headquarters60 Dorim-gil, Cheonan-si, South Korea, Korea
Websitehttps://www.sewoonmedical.co.kr

Leadership

Ms. Jae-Hee LeeChief Exec. Officer · b. 1971
Mong-Doh HurManaging Director · b. 1964
Byung-Soon LeeManaging Director · b. 1943

Financials

Income Statement

Currency: KRW	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	44.25B	49.15B	51.42B	52.87B	55.87B	56.62B	61.23B	63.12B	66.87B	63.73B	62.58B	60.12B	68.25B	60.15B	63.66B
Growth (%)	-	+11.07%	+4.63%	+2.82%	+5.67%	+1.35%	+8.14%	+3.09%	+5.94%	-4.69%	-1.80%	-3.94%	+13.53%	-11.86%	+5.83%
Cost of Revenue	28.90B	31.59B	30.35B	31.69B	35.69B	34.73B	37.64B	34.77B	39.44B	40.00B	37.52B	37.90B	40.69B	37.96B	40.11B
Gross Profit	-	-	-	19.04B	20.18B	21.89B	23.59B	28.35B	27.43B	23.72B	25.06B	22.22B	27.56B	22.19B	23.55B
Gross Margin	-	-	-	36.01%	36.12%	38.66%	38.52%	44.91%	41.02%	37.23%	40.04%	36.96%	40.38%	36.89%	36.99%
Operating Expense	-	-	-	8.69B	10.72B	10.70B	11.12B	10.39B	10.52B	9.56B	9.67B	10.03B	10.64B	10.81B	10.84B
Operating Income	5.72B	7.14B	10.63B	10.35B	9.45B	11.19B	12.47B	17.96B	16.91B	14.16B	15.38B	12.19B	16.92B	11.38B	12.70B
Operating Margin	12.93%	14.54%	20.66%	19.58%	16.92%	19.76%	20.37%	28.45%	25.29%	22.22%	24.58%	20.27%	24.79%	18.91%	19.95%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	17.55B	22.98B	19.14B	18.26B
EBITDA Margin	-	-	-	-	-	-	-	-	-	-	-	29.20%	33.68%	31.82%	28.68%
Net Income	3.68B	5.27B	8.52B	5.99B	3.06B	8.35B	9.18B	9.67B	9.48B	10.50B	12.28B	10.41B	14.96B	12.16B	11.91B
Net Income Margin	8.32%	10.73%	16.57%	11.33%	5.49%	14.74%	14.99%	15.32%	14.17%	16.47%	19.63%	17.31%	21.92%	20.22%	18.71%
R&D	109.06M	-	525.16M	612.45M	380.50M	222.69M	269.27M	245.81M	340.23M	321.38M	427.87M	505.09M	468.21M	510.42M	456.39M
R&D as % of Total Revenue	0.25%	-	1.02%	1.16%	0.68%	0.39%	0.44%	0.39%	0.51%	0.50%	0.68%	0.84%	0.69%	0.85%	0.72%
Interest Expense	0	0	0	0	0	0	0	0	40.44M	31.63M	31.47M	35.81M	36.08M	36.63M	35.52M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.05%	0.05%	0.06%	0.05%	0.06%	0.06%

Balance Sheet

Currency: KRW	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	55.13B	56.28B	64.64B	73.00B	78.64B	85.31B	86.06B	96.87B	104.47B	109.53B	124.72B	132.48B	146.61B	156.85B	163.87B
Total Liabilities	8.42B	5.03B	5.92B	8.65B	13.02B	12.22B	8.35B	10.52B	9.26B	7.55B	10.59B	9.47B	8.92B	10.73B	9.47B
Total Equity	45.86B	50.26B	57.83B	63.33B	65.61B	73.09B	77.72B	86.35B	95.22B	101.98B	114.13B	123.01B	135.16B	146.12B	151.17B
Cash	2.11B	4.21B	9.54B	9.61B	8.49B	10.62B	8.35B	17.63B	20.34B	34.64B	1.72M	420.00K	75.71B	2.22M	97.02B
Total Debt	-	-	-	-	-	-	-	-	613.19M	701.10M	-	-	-	-	-

Cash Flow

Currency: KRW	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	5.16B	7.19B	9.62B	8.40B	3.65B	6.35B	8.23B	12.19B	13.48B	19.25B	21.47B	9.28B	23.08B	13.19B	17.77B
Investing Cash Flow	-	-	-	-7.55B	-3.83B	-7.85B	-4.69B	-3.55B	-5.61B	-2.53B	-9.18B	-19.82B	23.64B	-349.15M	-
Financing Cash Flow	-	-	-	-1.04B	-1.18B	2.92B	-5.70B	489.62M	-4.77B	-2.32B	-2.44B	-2.46B	-2.89B	-3.29B	-
Capital Expenditure	2.92B	850.67M	1.68B	7.59B	4.21B	7.87B	5.04B	5.41B	5.93B	2.27B	2.22B	2.17B	1.96B	1.65B	1.70B
Free Cash Flow	-	-	-	-	-	-	-	-	8.52B	15.76B	18.98B	7.11B	21.12B	11.53B	16.07B
Dividends Paid	649.37M	649.37M	692.66M	865.82M	1.08B	1.08B	1.86B	1.73B	2.16B	2.16B	2.16B	2.16B	2.60B	3.03B	2.60B
FCF to OCF	-	-	-	-	-	-	-	-	63.21%	81.88%	88.40%	76.64%	91.52%	87.47%	90.44%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	25.40%	13.73%	11.40%	30.44%	12.30%	26.27%	16.16%

Earnings

Report Date	Mar 31, 2009	Jun 30, 2009	Sep 30, 2009	Dec 31, 2009	Mar 31, 2010	Jun 30, 2010	Sep 30, 2010	Dec 31, 2010	Dec 31, 2011	Mar 31, 2012	Jun 30, 2012	Sep 30, 2012	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Nov 5, 2014	Mar 20, 2015	May 6, 2015	Jul 30, 2015	Nov 13, 2015	Feb 26, 2016	May 13, 2016	Aug 10, 2016	Nov 3, 2016	Feb 24, 2017	May 11, 2017	Aug 11, 2017	Nov 13, 2017	Feb 23, 2018	May 14, 2018	Aug 14, 2018	Nov 13, 2018	Feb 28, 2019	May 14, 2019	Aug 14, 2019	Nov 14, 2019	Mar 16, 2020	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Mar 19, 2021	May 14, 2021	Aug 13, 2021	Nov 12, 2021	Mar 23, 2022	May 13, 2022	Aug 12, 2022	Nov 11, 2022	Mar 21, 2023	May 15, 2023	Aug 14, 2023	Nov 14, 2023	Feb 28, 2024	May 16, 2024	Aug 14, 2024	Nov 12, 2024	Feb 26, 2025	May 14, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	36.21	34.10	108.77	42.06	25.61	34.59	22.06	19.90	8.98	29.11	30.37	36.47	17.93	44.18	50.79	52.04	49.77	59.74	22.42	56.23	0.02	40.58	52.32	-61.84	39.73	46.51	67.26	55.60	23.43	54.49	41.19	61.23	57.80	63.25	60.62	63.00	36.00	60.21	69.71	76.80	12.18	63.82	84.90	72.54	21.18	79.50	66.67	79.98	57.55	57.72	62.36	70.91	49.40	89.25	84.31	105.82	66.11	86.77	68.04	53.62	72.53	63.07	44.87	87.26	84.00	81.37
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	-	-	-

Key Statistics & Ratios

Market Cap96.80B

Enterprise Value-1.93B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.45

Price / Book0.62

Revenue (TTM)60.27B

Gross Profit (TTM)25.06B

EBITDA16.68B

Profit Margin17.85%

Operating Margin21.19%

Return on Equity788.70%

Return on Assets6.26%

Shares Outstanding43.29M

Shares Float20.12M

Beta0.98

Dividend Yield2.46%

Dividend Rate0.00

Payout Ratio27.71%

Dividends

20251×

70.00Dec 29, 2025

20241×

60.00Dec 27, 2024

20231×

70.00Dec 27, 2023

20221×

60.00Dec 28, 2022

20211×

50.00Dec 29, 2021

20201×

50.00Dec 29, 2020

20191×

50.00Dec 27, 2019

20181×

50.00Dec 27, 2018

20171×

40.00Dec 27, 2017

20161×

35.00Dec 28, 2016

20151×

25.00Dec 29, 2015

20141×

25.00Dec 29, 2014

20131×

20.00Dec 27, 2013

20121×

16.00Dec 27, 2012

20111×

15.00Dec 28, 2011

20101×

15.00Dec 29, 2010

20091×

14.00Dec 29, 2009

20081×

10.00Dec 29, 2008

Stock Splits

Sep 24, 20092:1
Jul 23, 20095:1